Brooks Life Sciences Competitors and Similar CompaniesClear all

Brooks Life Sciences's competitors and similar companies include EPL Archives, Boston Analytical, Bioiberica and BioCryst Pharmaceuticals.

	Brooks Life Sciences Brooks Life Sciences is a company specializing in automated sample management for drug discovery and biostorage applications.	EPL Archives EPL Archives (also known as Avantor Clinical Services) is a company providing clinical research and data and material management services.	Boston Analytical Boston Analytical is a company that provides analytical testing services to support CMC for drug development and release testing.	Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.	BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
Founding Date	Founding Date 1981	Founding Date 1978	Founding Date 1987	Founding Date 1975	Founding Date 1986
Type	Type Subsidiary	Type Subsidiary	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech drug development life sciences pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development life sciences pharma	Tags Healthcare biotech drug development life sciences pharma	Tags Healthcare biotech drug development life sciences pharma
Locations	Locations Burlington, US HQ Laval, CA Montréal, CA Beijing, CN Guangzhou, CN Suzhou, CN see more	Locations Leesburg, US HQ Carros, FR	Locations Salem, US HQ	Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES	Locations Durham, US HQ Hoover, US
Employees	Employees 5661% decrease	Employees 1711% decrease	Employees 2441% decrease	Employees 332	Employees 14040% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $346.7m (FY, 2018)	Revenue (est.) $874.8m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $190.3m (FY, 2018)	Cost of goods $19.1m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $156.4m (FY, 2018)	Gross profit $855.8m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income $40.5m (FY, 2018)	Net income $263.9m (FY, 2025)